Search research articles
Contact Us
Filters
Showing results (1-10 of 136) with videos related to
Page
of 14
Sort By:
Current Medicinal Chemistry
|
November 30, 2007
Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications
Jacques Fantini
FEBS Open Bio
|
April 13, 2023
Lipid rafts and human diseases: why we need to target gangliosides
Jacques Fantini
Viruses
|
January 28, 2026
Advanced Strategies Against SARS-CoV-2 Variants and Future Emerging Virus Outbreaks
Jacques Fantini
Biomolecular Concepts
|
February 21, 2022
The epigenetic dimension of protein structure
Fodil Azzaz, Jacques Fantini
Neural Regeneration Research
|
July 10, 2025
Targeting gangliosides to treat Alzheimer's and Parkinson's diseases: A disruptive approach with the first-in-class peptide AmyP53
Jacques Fantini, Nouara Yahi
Plos One
|
August 21, 2014
Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide
Nouara Yahi, Jacques Fantini
Journal of Molecular Biology
|
March 15, 2011
Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion
Jacques Fantini, Nouara Yahi
Expert Reviews in Molecular Medicine
|
September 3, 2010
Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases
Jacques Fantini, Nouara Yahi
Toxicon : Official Journal of the International Society on Toxinology
|
May 15, 2010
Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases
Marc Maresca, Jacques Fantini
Advances in Experimental Medicine and Biology
|
June 19, 2013
The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains
Jacques Fantini, Nouara Yahi
Page
of 14
Search research articles
Search
Showing results (1-10 of 136) with videos related to
Sort By:
Page
of 14
Current Medicinal Chemistry
|
November 30, 2007
Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications
Jacques Fantini
FEBS Open Bio
|
April 13, 2023
Lipid rafts and human diseases: why we need to target gangliosides
Jacques Fantini
Viruses
|
January 28, 2026
Advanced Strategies Against SARS-CoV-2 Variants and Future Emerging Virus Outbreaks
Jacques Fantini
Biomolecular Concepts
|
February 21, 2022
The epigenetic dimension of protein structure
Fodil Azzaz, Jacques Fantini
Neural Regeneration Research
|
July 10, 2025
Targeting gangliosides to treat Alzheimer's and Parkinson's diseases: A disruptive approach with the first-in-class peptide AmyP53
Jacques Fantini, Nouara Yahi
Plos One
|
August 21, 2014
Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide
Nouara Yahi, Jacques Fantini
Journal of Molecular Biology
|
March 15, 2011
Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion
Jacques Fantini, Nouara Yahi
Expert Reviews in Molecular Medicine
|
September 3, 2010
Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases
Jacques Fantini, Nouara Yahi
Toxicon : Official Journal of the International Society on Toxinology
|
May 15, 2010
Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases
Marc Maresca, Jacques Fantini
Advances in Experimental Medicine and Biology
|
June 19, 2013
The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains
Jacques Fantini, Nouara Yahi
Page
of 14